Exploring Rural Health Disparities in Alzheimer's Disease
Principal Investigator
Justin Miller, PhD
University of Washington School of Medicine
Seattle, WA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2024 - June 30, 2027
Grant ID
A2024037S
Goals
Our goal is to characterize cognitive aging and biological markers of Alzheimer’s disease and related dementia in adults and older adults aging in rural communities.
Summary
There is emerging evidence that older adults living in rural communities are at increased risk for Alzheimer’s disease (AD); however, rural communities have been severely underrepresented in AD research, and the factors that may be contributing to these urban-rural disparities are unclear. Our long-term goal is to fully characterize cognitive aging and validate AD-specific biomarkers among rural-dwelling older adults. This project will enrich the biomarker characterization of our rural cohort and facilitate identification of the most viable blood markers for use in rural-dwelling older adults.
Unique and Innovative
Rural populations have been severely underrepresnted in aging research, and most research done has been retrospective. The proposed project will lay the foundation to establish community cohort of rural-dwelling adults focusing with the specific goal of studying cognitive aging and the factors leading to health disparities faced by this population.
Foreseeable Benefits
The proposed project will create a valuable community cohort of rural older adults, addressing their underrepresentation in aging research. Insights gained will shed light on the factors contributing to urban-rural AD/ADRD disparities that can be used to inform public health campaigns and other novel interventions to target these chronic diseases in rural communities.
Related Grants
Alzheimer's Disease Research
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Defining Immunometabolic Contributions to Cognitive Impairment in Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Caleb Bailey, PhD
Current Organization
University of Kentucky Research Foundation
Alzheimer's Disease Research
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Understanding the Link Between Alzheimer's Disease Risk Genes and Immune Responses in the Brain
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Amanda McQuade, PhD
Current Organization
University of California, San Francisco
Alzheimer's Disease Research
Developing a Noninvasive Gene Therapy for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Dominika Pilat, PhD
Current Organization
Massachusetts General Hospital
Developing a Noninvasive Gene Therapy for Alzheimer's Disease
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Dominika Pilat, PhD
Current Organization
Massachusetts General Hospital